nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR1D—meninx—brain cancer	0.029	0.0743	CbGeAlD
Pramipexole—HTR1B—dura mater—brain cancer	0.0276	0.0706	CbGeAlD
Pramipexole—HTR1D—dura mater—brain cancer	0.0267	0.0684	CbGeAlD
Pramipexole—HTR2C—choroid plexus—brain cancer	0.0225	0.0576	CbGeAlD
Pramipexole—HTR1B—trigeminal nerve—brain cancer	0.0119	0.0304	CbGeAlD
Pramipexole—DRD3—telencephalic ventricle—brain cancer	0.0118	0.0303	CbGeAlD
Pramipexole—HTR1D—trigeminal nerve—brain cancer	0.0115	0.0294	CbGeAlD
Pramipexole—HTR2A—choroid plexus—brain cancer	0.0113	0.0289	CbGeAlD
Pramipexole—DRD1—telencephalic ventricle—brain cancer	0.00848	0.0217	CbGeAlD
Pramipexole—HTR1B—cranial nerve—brain cancer	0.00845	0.0216	CbGeAlD
Pramipexole—HTR1D—cranial nerve—brain cancer	0.00818	0.0209	CbGeAlD
Pramipexole—DRD5—ganglion—brain cancer	0.00691	0.0177	CbGeAlD
Pramipexole—HTR1B—telencephalic ventricle—brain cancer	0.00687	0.0176	CbGeAlD
Pramipexole—HTR1D—telencephalic ventricle—brain cancer	0.00665	0.017	CbGeAlD
Pramipexole—HTR2C—telencephalic ventricle—brain cancer	0.00659	0.0169	CbGeAlD
Pramipexole—HTR2A—trigeminal nerve—brain cancer	0.0057	0.0146	CbGeAlD
Pramipexole—HTR2A—cerebellar cortex—brain cancer	0.00568	0.0145	CbGeAlD
Pramipexole—HTR1A—telencephalic ventricle—brain cancer	0.00554	0.0142	CbGeAlD
Pramipexole—DRD1—ganglion—brain cancer	0.00528	0.0135	CbGeAlD
Pramipexole—HTR2A—vein—brain cancer	0.00515	0.0132	CbGeAlD
Pramipexole—DRD2—telencephalic ventricle—brain cancer	0.00501	0.0128	CbGeAlD
Pramipexole—HTR1B—ganglion—brain cancer	0.00428	0.0109	CbGeAlD
Pramipexole—SLC22A1—ganglion—brain cancer	0.00418	0.0107	CbGeAlD
Pramipexole—HTR1D—ganglion—brain cancer	0.00414	0.0106	CbGeAlD
Pramipexole—HTR2C—ganglion—brain cancer	0.0041	0.0105	CbGeAlD
Pramipexole—HTR2A—cranial nerve—brain cancer	0.00406	0.0104	CbGeAlD
Pramipexole—HTR2A—pons—brain cancer	0.00402	0.0103	CbGeAlD
Pramipexole—HTR1A—ganglion—brain cancer	0.00345	0.00884	CbGeAlD
Pramipexole—HTR1B—blood vessel—brain cancer	0.0034	0.00871	CbGeAlD
Pramipexole—HTR2A—telencephalic ventricle—brain cancer	0.0033	0.00846	CbGeAlD
Pramipexole—HTR1D—blood vessel—brain cancer	0.00329	0.00843	CbGeAlD
Pramipexole—DRD2—ganglion—brain cancer	0.00312	0.00798	CbGeAlD
Pramipexole—HTR2A—pineal body—brain cancer	0.00287	0.00734	CbGeAlD
Pramipexole—DRD5—telencephalon—brain cancer	0.00266	0.00682	CbGeAlD
Pramipexole—HTR1A—hindbrain—brain cancer	0.00262	0.0067	CbGeAlD
Pramipexole—DRD2—hindbrain—brain cancer	0.00236	0.00606	CbGeAlD
Pramipexole—DRD1—brainstem—brain cancer	0.00229	0.00587	CbGeAlD
Pramipexole—HTR2A—ganglion—brain cancer	0.00206	0.00527	CbGeAlD
Pramipexole—DRD1—telencephalon—brain cancer	0.00204	0.00521	CbGeAlD
Pramipexole—HTR1B—brainstem—brain cancer	0.00186	0.00476	CbGeAlD
Pramipexole—DRD4—brain—brain cancer	0.00183	0.00467	CbGeAlD
Pramipexole—HTR1D—brainstem—brain cancer	0.0018	0.00461	CbGeAlD
Pramipexole—HTR2C—brainstem—brain cancer	0.00178	0.00456	CbGeAlD
Pramipexole—HTR2A—endothelium—brain cancer	0.00177	0.00454	CbGeAlD
Pramipexole—DRD3—head—brain cancer	0.00177	0.00453	CbGeAlD
Pramipexole—DRD5—endocrine gland—brain cancer	0.00168	0.0043	CbGeAlD
Pramipexole—DRD5—head—brain cancer	0.00166	0.00425	CbGeAlD
Pramipexole—HTR1B—telencephalon—brain cancer	0.00165	0.00422	CbGeAlD
Pramipexole—HTR2A—blood vessel—brain cancer	0.00164	0.00419	CbGeAlD
Pramipexole—DRD3—central nervous system—brain cancer	0.00162	0.00414	CbGeAlD
Pramipexole—SLC22A1—telencephalon—brain cancer	0.00161	0.00413	CbGeAlD
Pramipexole—HTR1D—telencephalon—brain cancer	0.0016	0.00409	CbGeAlD
Pramipexole—HTR2C—telencephalon—brain cancer	0.00158	0.00405	CbGeAlD
Pramipexole—HTR2A—hindbrain—brain cancer	0.00156	0.00399	CbGeAlD
Pramipexole—DRD5—central nervous system—brain cancer	0.00151	0.00388	CbGeAlD
Pramipexole—HTR1A—brainstem—brain cancer	0.0015	0.00384	CbGeAlD
Pramipexole—HTR2B—telencephalon—brain cancer	0.00149	0.0038	CbGeAlD
Pramipexole—DRD1—midbrain—brain cancer	0.00146	0.00374	CbGeAlD
Pramipexole—DRD2—brainstem—brain cancer	0.00136	0.00347	CbGeAlD
Pramipexole—HTR1A—telencephalon—brain cancer	0.00133	0.00341	CbGeAlD
Pramipexole—DRD3—brain—brain cancer	0.00128	0.00329	CbGeAlD
Pramipexole—DRD1—head—brain cancer	0.00127	0.00325	CbGeAlD
Pramipexole—HTR2C—medulla oblongata—brain cancer	0.00124	0.00318	CbGeAlD
Pramipexole—DRD2—telencephalon—brain cancer	0.0012	0.00308	CbGeAlD
Pramipexole—DRD5—brain—brain cancer	0.0012	0.00308	CbGeAlD
Pramipexole—HTR1B—midbrain—brain cancer	0.00118	0.00303	CbGeAlD
Pramipexole—ADRA2C—telencephalon—brain cancer	0.00117	0.00299	CbGeAlD
Pramipexole—DRD1—central nervous system—brain cancer	0.00116	0.00296	CbGeAlD
Pramipexole—HTR1B—spinal cord—brain cancer	0.00116	0.00296	CbGeAlD
Pramipexole—HTR1D—midbrain—brain cancer	0.00115	0.00294	CbGeAlD
Pramipexole—HTR2C—midbrain—brain cancer	0.00114	0.00291	CbGeAlD
Pramipexole—HTR2C—spinal cord—brain cancer	0.00111	0.00284	CbGeAlD
Pramipexole—HTR1B—endocrine gland—brain cancer	0.00104	0.00266	CbGeAlD
Pramipexole—HTR1B—head—brain cancer	0.00103	0.00263	CbGeAlD
Pramipexole—SLC22A1—endocrine gland—brain cancer	0.00102	0.0026	CbGeAlD
Pramipexole—SLC22A1—head—brain cancer	0.001	0.00257	CbGeAlD
Pramipexole—HTR1D—head—brain cancer	0.000995	0.00255	CbGeAlD
Pramipexole—HTR2C—head—brain cancer	0.000985	0.00252	CbGeAlD
Pramipexole—DRD2—pituitary gland—brain cancer	0.000979	0.00251	CbGeAlD
Pramipexole—HTR1A—midbrain—brain cancer	0.000956	0.00245	CbGeAlD
Pramipexole—ADRA2C—pituitary gland—brain cancer	0.000952	0.00244	CbGeAlD
Pramipexole—HTR1B—central nervous system—brain cancer	0.000938	0.0024	CbGeAlD
Pramipexole—ADRA2A—telencephalon—brain cancer	0.000933	0.00239	CbGeAlD
Pramipexole—HTR1A—spinal cord—brain cancer	0.000933	0.00239	CbGeAlD
Pramipexole—HTR2B—head—brain cancer	0.000925	0.00237	CbGeAlD
Pramipexole—ADRA2C—medulla oblongata—brain cancer	0.000919	0.00235	CbGeAlD
Pramipexole—DRD1—brain—brain cancer	0.000919	0.00235	CbGeAlD
Pramipexole—SLC22A1—central nervous system—brain cancer	0.000916	0.00235	CbGeAlD
Pramipexole—HTR1D—central nervous system—brain cancer	0.000908	0.00232	CbGeAlD
Pramipexole—HTR2C—central nervous system—brain cancer	0.000899	0.0023	CbGeAlD
Pramipexole—HTR2A—brainstem—brain cancer	0.000894	0.00229	CbGeAlD
Pramipexole—DRD2—midbrain—brain cancer	0.000864	0.00221	CbGeAlD
Pramipexole—HTR2B—central nervous system—brain cancer	0.000844	0.00216	CbGeAlD
Pramipexole—ADRA2C—midbrain—brain cancer	0.00084	0.00215	CbGeAlD
Pramipexole—HTR1A—endocrine gland—brain cancer	0.00084	0.00215	CbGeAlD
Pramipexole—HTR1A—head—brain cancer	0.000829	0.00212	CbGeAlD
Pramipexole—ADRA2C—spinal cord—brain cancer	0.000819	0.0021	CbGeAlD
Pramipexole—HTR2A—telencephalon—brain cancer	0.000793	0.00203	CbGeAlD
Pramipexole—ADRA2A—gonad—brain cancer	0.000779	0.00199	CbGeAlD
Pramipexole—ADRA2A—pituitary gland—brain cancer	0.00076	0.00195	CbGeAlD
Pramipexole—DRD2—endocrine gland—brain cancer	0.000759	0.00194	CbGeAlD
Pramipexole—HTR1A—central nervous system—brain cancer	0.000757	0.00194	CbGeAlD
Pramipexole—DRD2—head—brain cancer	0.000749	0.00192	CbGeAlD
Pramipexole—HTR1B—brain—brain cancer	0.000744	0.00191	CbGeAlD
Pramipexole—HTR1A—cerebellum—brain cancer	0.00074	0.00189	CbGeAlD
Pramipexole—ADRA2A—medulla oblongata—brain cancer	0.000733	0.00188	CbGeAlD
Pramipexole—ADRA2C—head—brain cancer	0.000728	0.00186	CbGeAlD
Pramipexole—SLC22A1—brain—brain cancer	0.000727	0.00186	CbGeAlD
Pramipexole—HTR1D—brain—brain cancer	0.000721	0.00185	CbGeAlD
Pramipexole—HTR2C—brain—brain cancer	0.000714	0.00183	CbGeAlD
Pramipexole—DRD2—central nervous system—brain cancer	0.000684	0.00175	CbGeAlD
Pramipexole—HTR2B—brain—brain cancer	0.00067	0.00172	CbGeAlD
Pramipexole—ADRA2A—midbrain—brain cancer	0.00067	0.00172	CbGeAlD
Pramipexole—DRD2—cerebellum—brain cancer	0.000668	0.00171	CbGeAlD
Pramipexole—ADRA2C—central nervous system—brain cancer	0.000665	0.0017	CbGeAlD
Pramipexole—HTR2A—gonad—brain cancer	0.000662	0.0017	CbGeAlD
Pramipexole—ADRA2A—spinal cord—brain cancer	0.000654	0.00167	CbGeAlD
Pramipexole—ADRA2C—cerebellum—brain cancer	0.00065	0.00166	CbGeAlD
Pramipexole—HTR2A—pituitary gland—brain cancer	0.000646	0.00165	CbGeAlD
Pramipexole—HTR2A—medulla oblongata—brain cancer	0.000623	0.0016	CbGeAlD
Pramipexole—HTR1A—brain—brain cancer	0.000601	0.00154	CbGeAlD
Pramipexole—Urinary tract infection—Temozolomide—brain cancer	0.000597	0.00109	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00059	0.00108	CcSEcCtD
Pramipexole—ADRA2A—endocrine gland—brain cancer	0.000589	0.00151	CbGeAlD
Pramipexole—Insomnia—Procarbazine—brain cancer	0.000586	0.00107	CcSEcCtD
Pramipexole—Paraesthesia—Procarbazine—brain cancer	0.000581	0.00106	CcSEcCtD
Pramipexole—ADRA2A—head—brain cancer	0.000581	0.00149	CbGeAlD
Pramipexole—Hepatobiliary disease—Temozolomide—brain cancer	0.000581	0.00106	CcSEcCtD
Pramipexole—Sinusitis—Temozolomide—brain cancer	0.000576	0.00105	CcSEcCtD
Pramipexole—Somnolence—Procarbazine—brain cancer	0.000576	0.00105	CcSEcCtD
Pramipexole—Cramp muscle—Etoposide—brain cancer	0.000574	0.00105	CcSEcCtD
Pramipexole—HTR2A—midbrain—brain cancer	0.00057	0.00146	CbGeAlD
Pramipexole—Ill-defined disorder—Hydroxyurea—brain cancer	0.00057	0.00104	CcSEcCtD
Pramipexole—Anaemia—Hydroxyurea—brain cancer	0.000568	0.00104	CcSEcCtD
Pramipexole—Hypoaesthesia—Carmustine—brain cancer	0.000567	0.00104	CcSEcCtD
Pramipexole—Hallucination—Carmustine—brain cancer	0.000567	0.00104	CcSEcCtD
Pramipexole—Decreased appetite—Procarbazine—brain cancer	0.000563	0.00103	CcSEcCtD
Pramipexole—Oedema peripheral—Carmustine—brain cancer	0.000562	0.00103	CcSEcCtD
Pramipexole—Connective tissue disorder—Carmustine—brain cancer	0.00056	0.00103	CcSEcCtD
Pramipexole—Fatigue—Procarbazine—brain cancer	0.000558	0.00102	CcSEcCtD
Pramipexole—HTR2A—spinal cord—brain cancer	0.000556	0.00142	CbGeAlD
Pramipexole—Malaise—Hydroxyurea—brain cancer	0.000554	0.00101	CcSEcCtD
Pramipexole—Constipation—Procarbazine—brain cancer	0.000554	0.00101	CcSEcCtD
Pramipexole—Pain—Procarbazine—brain cancer	0.000554	0.00101	CcSEcCtD
Pramipexole—Dysphagia—Etoposide—brain cancer	0.000551	0.00101	CcSEcCtD
Pramipexole—Leukopenia—Hydroxyurea—brain cancer	0.00055	0.00101	CcSEcCtD
Pramipexole—Visual impairment—Carmustine—brain cancer	0.000549	0.00101	CcSEcCtD
Pramipexole—Hallucination—Temozolomide—brain cancer	0.000548	0.001	CcSEcCtD
Pramipexole—Hypoaesthesia—Temozolomide—brain cancer	0.000548	0.001	CcSEcCtD
Pramipexole—Pharyngitis—Temozolomide—brain cancer	0.000547	0.001	CcSEcCtD
Pramipexole—Urinary tract disorder—Temozolomide—brain cancer	0.000544	0.000996	CcSEcCtD
Pramipexole—Oedema peripheral—Temozolomide—brain cancer	0.000543	0.000994	CcSEcCtD
Pramipexole—DRD2—brain—brain cancer	0.000543	0.00139	CbGeAlD
Pramipexole—Connective tissue disorder—Temozolomide—brain cancer	0.000541	0.000991	CcSEcCtD
Pramipexole—Urethral disorder—Temozolomide—brain cancer	0.00054	0.000989	CcSEcCtD
Pramipexole—Feeling abnormal—Procarbazine—brain cancer	0.000534	0.000977	CcSEcCtD
Pramipexole—Eye disorder—Carmustine—brain cancer	0.000533	0.000976	CcSEcCtD
Pramipexole—Convulsion—Hydroxyurea—brain cancer	0.000532	0.000974	CcSEcCtD
Pramipexole—Visual impairment—Temozolomide—brain cancer	0.000531	0.000972	CcSEcCtD
Pramipexole—ADRA2A—central nervous system—brain cancer	0.00053	0.00136	CbGeAlD
Pramipexole—Gastrointestinal pain—Procarbazine—brain cancer	0.000529	0.000969	CcSEcCtD
Pramipexole—Flushing—Carmustine—brain cancer	0.000529	0.000969	CcSEcCtD
Pramipexole—ADRA2C—brain—brain cancer	0.000528	0.00135	CbGeAlD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000519	0.00095	CcSEcCtD
Pramipexole—ADRA2A—cerebellum—brain cancer	0.000518	0.00133	CbGeAlD
Pramipexole—Discomfort—Hydroxyurea—brain cancer	0.000516	0.000946	CcSEcCtD
Pramipexole—Eye disorder—Temozolomide—brain cancer	0.000515	0.000943	CcSEcCtD
Pramipexole—Urticaria—Procarbazine—brain cancer	0.000514	0.000942	CcSEcCtD
Pramipexole—Tinnitus—Temozolomide—brain cancer	0.000514	0.000941	CcSEcCtD
Pramipexole—Abdominal pain—Procarbazine—brain cancer	0.000512	0.000937	CcSEcCtD
Pramipexole—Body temperature increased—Procarbazine—brain cancer	0.000512	0.000937	CcSEcCtD
Pramipexole—Flushing—Temozolomide—brain cancer	0.000511	0.000936	CcSEcCtD
Pramipexole—Cardiac disorder—Temozolomide—brain cancer	0.000511	0.000936	CcSEcCtD
Pramipexole—Alopecia—Carmustine—brain cancer	0.000504	0.000922	CcSEcCtD
Pramipexole—Oedema—Hydroxyurea—brain cancer	0.000501	0.000917	CcSEcCtD
Pramipexole—HTR2A—endocrine gland—brain cancer	0.0005	0.00128	CbGeAlD
Pramipexole—Angiopathy—Temozolomide—brain cancer	0.0005	0.000915	CcSEcCtD
Pramipexole—Mental disorder—Carmustine—brain cancer	0.0005	0.000915	CcSEcCtD
Pramipexole—Infection—Hydroxyurea—brain cancer	0.000498	0.000911	CcSEcCtD
Pramipexole—Immune system disorder—Temozolomide—brain cancer	0.000498	0.000911	CcSEcCtD
Pramipexole—Mediastinal disorder—Temozolomide—brain cancer	0.000497	0.000909	CcSEcCtD
Pramipexole—Erythema—Carmustine—brain cancer	0.000496	0.000909	CcSEcCtD
Pramipexole—Malnutrition—Carmustine—brain cancer	0.000496	0.000909	CcSEcCtD
Pramipexole—Chills—Temozolomide—brain cancer	0.000494	0.000905	CcSEcCtD
Pramipexole—HTR2A—head—brain cancer	0.000494	0.00126	CbGeAlD
Pramipexole—Pneumonia—Etoposide—brain cancer	0.000494	0.000904	CcSEcCtD
Pramipexole—Nervous system disorder—Hydroxyurea—brain cancer	0.000491	0.0009	CcSEcCtD
Pramipexole—Infestation NOS—Etoposide—brain cancer	0.000491	0.000899	CcSEcCtD
Pramipexole—Infestation—Etoposide—brain cancer	0.000491	0.000899	CcSEcCtD
Pramipexole—Thrombocytopenia—Hydroxyurea—brain cancer	0.000491	0.000898	CcSEcCtD
Pramipexole—Alopecia—Temozolomide—brain cancer	0.000487	0.000891	CcSEcCtD
Pramipexole—Skin disorder—Hydroxyurea—brain cancer	0.000487	0.000891	CcSEcCtD
Pramipexole—Acute coronary syndrome—Etoposide—brain cancer	0.000484	0.000886	CcSEcCtD
Pramipexole—Renal failure—Etoposide—brain cancer	0.000483	0.000884	CcSEcCtD
Pramipexole—Mental disorder—Temozolomide—brain cancer	0.000483	0.000884	CcSEcCtD
Pramipexole—Neuropathy peripheral—Etoposide—brain cancer	0.000481	0.000881	CcSEcCtD
Pramipexole—Myocardial infarction—Etoposide—brain cancer	0.000481	0.000881	CcSEcCtD
Pramipexole—Back pain—Carmustine—brain cancer	0.00048	0.000879	CcSEcCtD
Pramipexole—Malnutrition—Temozolomide—brain cancer	0.00048	0.000878	CcSEcCtD
Pramipexole—Erythema—Temozolomide—brain cancer	0.00048	0.000878	CcSEcCtD
Pramipexole—Anorexia—Hydroxyurea—brain cancer	0.000478	0.000874	CcSEcCtD
Pramipexole—Hypersensitivity—Procarbazine—brain cancer	0.000477	0.000873	CcSEcCtD
Pramipexole—Dysgeusia—Temozolomide—brain cancer	0.00047	0.00086	CcSEcCtD
Pramipexole—Vision blurred—Carmustine—brain cancer	0.000468	0.000856	CcSEcCtD
Pramipexole—Tremor—Carmustine—brain cancer	0.000465	0.000851	CcSEcCtD
Pramipexole—Asthenia—Procarbazine—brain cancer	0.000465	0.000851	CcSEcCtD
Pramipexole—Hepatobiliary disease—Etoposide—brain cancer	0.000465	0.00085	CcSEcCtD
Pramipexole—Back pain—Temozolomide—brain cancer	0.000464	0.000849	CcSEcCtD
Pramipexole—Anaemia—Carmustine—brain cancer	0.000459	0.00084	CcSEcCtD
Pramipexole—Pruritus—Procarbazine—brain cancer	0.000458	0.000839	CcSEcCtD
Pramipexole—Agitation—Carmustine—brain cancer	0.000456	0.000835	CcSEcCtD
Pramipexole—Vision blurred—Temozolomide—brain cancer	0.000452	0.000828	CcSEcCtD
Pramipexole—HTR2A—central nervous system—brain cancer	0.000451	0.00115	CbGeAlD
Pramipexole—Tremor—Temozolomide—brain cancer	0.000449	0.000823	CcSEcCtD
Pramipexole—Dyspnoea—Hydroxyurea—brain cancer	0.000447	0.000818	CcSEcCtD
Pramipexole—Somnolence—Hydroxyurea—brain cancer	0.000445	0.000816	CcSEcCtD
Pramipexole—Ill-defined disorder—Temozolomide—brain cancer	0.000445	0.000815	CcSEcCtD
Pramipexole—Leukopenia—Carmustine—brain cancer	0.000444	0.000813	CcSEcCtD
Pramipexole—Anaemia—Temozolomide—brain cancer	0.000443	0.000812	CcSEcCtD
Pramipexole—Diarrhoea—Procarbazine—brain cancer	0.000443	0.000811	CcSEcCtD
Pramipexole—Dyspepsia—Hydroxyurea—brain cancer	0.000441	0.000808	CcSEcCtD
Pramipexole—Agitation—Temozolomide—brain cancer	0.000441	0.000807	CcSEcCtD
Pramipexole—HTR2A—cerebellum—brain cancer	0.000441	0.00113	CbGeAlD
Pramipexole—Hypoaesthesia—Etoposide—brain cancer	0.000439	0.000803	CcSEcCtD
Pramipexole—Decreased appetite—Hydroxyurea—brain cancer	0.000436	0.000798	CcSEcCtD
Pramipexole—Urinary tract disorder—Etoposide—brain cancer	0.000435	0.000797	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000433	0.000792	CcSEcCtD
Pramipexole—Malaise—Temozolomide—brain cancer	0.000433	0.000792	CcSEcCtD
Pramipexole—Urethral disorder—Etoposide—brain cancer	0.000432	0.000791	CcSEcCtD
Pramipexole—Fatigue—Hydroxyurea—brain cancer	0.000432	0.000791	CcSEcCtD
Pramipexole—Vertigo—Temozolomide—brain cancer	0.000431	0.000789	CcSEcCtD
Pramipexole—Convulsion—Carmustine—brain cancer	0.00043	0.000787	CcSEcCtD
Pramipexole—Leukopenia—Temozolomide—brain cancer	0.000429	0.000786	CcSEcCtD
Pramipexole—Hypertension—Carmustine—brain cancer	0.000429	0.000785	CcSEcCtD
Pramipexole—Pain—Hydroxyurea—brain cancer	0.000429	0.000785	CcSEcCtD
Pramipexole—Constipation—Hydroxyurea—brain cancer	0.000429	0.000785	CcSEcCtD
Pramipexole—Dizziness—Procarbazine—brain cancer	0.000428	0.000784	CcSEcCtD
Pramipexole—Palpitations—Temozolomide—brain cancer	0.000424	0.000776	CcSEcCtD
Pramipexole—Chest pain—Carmustine—brain cancer	0.000423	0.000774	CcSEcCtD
Pramipexole—Myalgia—Carmustine—brain cancer	0.000423	0.000774	CcSEcCtD
Pramipexole—Anxiety—Carmustine—brain cancer	0.000421	0.000771	CcSEcCtD
Pramipexole—ADRA2A—brain—brain cancer	0.000421	0.00108	CbGeAlD
Pramipexole—Cough—Temozolomide—brain cancer	0.000419	0.000766	CcSEcCtD
Pramipexole—Convulsion—Temozolomide—brain cancer	0.000416	0.000761	CcSEcCtD
Pramipexole—Hypertension—Temozolomide—brain cancer	0.000414	0.000758	CcSEcCtD
Pramipexole—Feeling abnormal—Hydroxyurea—brain cancer	0.000413	0.000756	CcSEcCtD
Pramipexole—Eye disorder—Etoposide—brain cancer	0.000412	0.000754	CcSEcCtD
Pramipexole—Vomiting—Procarbazine—brain cancer	0.000412	0.000754	CcSEcCtD
Pramipexole—Cardiac disorder—Etoposide—brain cancer	0.000409	0.000749	CcSEcCtD
Pramipexole—Flushing—Etoposide—brain cancer	0.000409	0.000749	CcSEcCtD
Pramipexole—Confusional state—Carmustine—brain cancer	0.000408	0.000748	CcSEcCtD
Pramipexole—Myalgia—Temozolomide—brain cancer	0.000408	0.000748	CcSEcCtD
Pramipexole—Arthralgia—Temozolomide—brain cancer	0.000408	0.000748	CcSEcCtD
Pramipexole—Rash—Procarbazine—brain cancer	0.000408	0.000747	CcSEcCtD
Pramipexole—Dermatitis—Procarbazine—brain cancer	0.000408	0.000747	CcSEcCtD
Pramipexole—Anxiety—Temozolomide—brain cancer	0.000407	0.000745	CcSEcCtD
Pramipexole—Headache—Procarbazine—brain cancer	0.000406	0.000743	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000406	0.000742	CcSEcCtD
Pramipexole—Oedema—Carmustine—brain cancer	0.000405	0.000742	CcSEcCtD
Pramipexole—Discomfort—Temozolomide—brain cancer	0.000403	0.000739	CcSEcCtD
Pramipexole—Infection—Carmustine—brain cancer	0.000402	0.000737	CcSEcCtD
Pramipexole—Angiopathy—Etoposide—brain cancer	0.0004	0.000732	CcSEcCtD
Pramipexole—Dry mouth—Temozolomide—brain cancer	0.000399	0.000731	CcSEcCtD
Pramipexole—Immune system disorder—Etoposide—brain cancer	0.000398	0.000729	CcSEcCtD
Pramipexole—Mediastinal disorder—Etoposide—brain cancer	0.000397	0.000728	CcSEcCtD
Pramipexole—Thrombocytopenia—Carmustine—brain cancer	0.000397	0.000726	CcSEcCtD
Pramipexole—Body temperature increased—Hydroxyurea—brain cancer	0.000396	0.000725	CcSEcCtD
Pramipexole—Chills—Etoposide—brain cancer	0.000396	0.000724	CcSEcCtD
Pramipexole—Tachycardia—Carmustine—brain cancer	0.000395	0.000724	CcSEcCtD
Pramipexole—Confusional state—Temozolomide—brain cancer	0.000395	0.000723	CcSEcCtD
Pramipexole—Oedema—Temozolomide—brain cancer	0.000391	0.000717	CcSEcCtD
Pramipexole—Alopecia—Etoposide—brain cancer	0.00039	0.000713	CcSEcCtD
Pramipexole—Infection—Temozolomide—brain cancer	0.000389	0.000712	CcSEcCtD
Pramipexole—Anorexia—Carmustine—brain cancer	0.000386	0.000707	CcSEcCtD
Pramipexole—Nausea—Procarbazine—brain cancer	0.000385	0.000704	CcSEcCtD
Pramipexole—Nervous system disorder—Temozolomide—brain cancer	0.000384	0.000703	CcSEcCtD
Pramipexole—Thrombocytopenia—Temozolomide—brain cancer	0.000383	0.000702	CcSEcCtD
Pramipexole—Skin disorder—Temozolomide—brain cancer	0.00038	0.000696	CcSEcCtD
Pramipexole—Hypotension—Carmustine—brain cancer	0.000379	0.000693	CcSEcCtD
Pramipexole—Hyperhidrosis—Temozolomide—brain cancer	0.000378	0.000693	CcSEcCtD
Pramipexole—Dysgeusia—Etoposide—brain cancer	0.000376	0.000688	CcSEcCtD
Pramipexole—Anorexia—Temozolomide—brain cancer	0.000373	0.000683	CcSEcCtD
Pramipexole—Back pain—Etoposide—brain cancer	0.000371	0.00068	CcSEcCtD
Pramipexole—Hypersensitivity—Hydroxyurea—brain cancer	0.000369	0.000676	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Carmustine—brain cancer	0.000369	0.000676	CcSEcCtD
Pramipexole—Muscle spasms—Etoposide—brain cancer	0.000369	0.000676	CcSEcCtD
Pramipexole—Insomnia—Carmustine—brain cancer	0.000366	0.000671	CcSEcCtD
Pramipexole—Paraesthesia—Carmustine—brain cancer	0.000364	0.000666	CcSEcCtD
Pramipexole—Dyspnoea—Carmustine—brain cancer	0.000361	0.000661	CcSEcCtD
Pramipexole—Somnolence—Carmustine—brain cancer	0.00036	0.000659	CcSEcCtD
Pramipexole—Asthenia—Hydroxyurea—brain cancer	0.00036	0.000658	CcSEcCtD
Pramipexole—HTR2A—brain—brain cancer	0.000358	0.000917	CbGeAlD
Pramipexole—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000357	0.000653	CcSEcCtD
Pramipexole—Ill-defined disorder—Etoposide—brain cancer	0.000356	0.000652	CcSEcCtD
Pramipexole—Anaemia—Etoposide—brain cancer	0.000355	0.000649	CcSEcCtD
Pramipexole—Insomnia—Temozolomide—brain cancer	0.000354	0.000648	CcSEcCtD
Pramipexole—Decreased appetite—Carmustine—brain cancer	0.000352	0.000645	CcSEcCtD
Pramipexole—Paraesthesia—Temozolomide—brain cancer	0.000352	0.000644	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Carmustine—brain cancer	0.00035	0.00064	CcSEcCtD
Pramipexole—Dyspnoea—Temozolomide—brain cancer	0.000349	0.000639	CcSEcCtD
Pramipexole—Somnolence—Temozolomide—brain cancer	0.000348	0.000637	CcSEcCtD
Pramipexole—Constipation—Carmustine—brain cancer	0.000346	0.000634	CcSEcCtD
Pramipexole—Pain—Carmustine—brain cancer	0.000346	0.000634	CcSEcCtD
Pramipexole—Malaise—Etoposide—brain cancer	0.000346	0.000634	CcSEcCtD
Pramipexole—Vertigo—Etoposide—brain cancer	0.000345	0.000631	CcSEcCtD
Pramipexole—Dyspepsia—Temozolomide—brain cancer	0.000345	0.000631	CcSEcCtD
Pramipexole—Leukopenia—Etoposide—brain cancer	0.000344	0.000629	CcSEcCtD
Pramipexole—Diarrhoea—Hydroxyurea—brain cancer	0.000343	0.000628	CcSEcCtD
Pramipexole—Decreased appetite—Temozolomide—brain cancer	0.00034	0.000623	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Temozolomide—brain cancer	0.000338	0.000619	CcSEcCtD
Pramipexole—Fatigue—Temozolomide—brain cancer	0.000338	0.000618	CcSEcCtD
Pramipexole—Loss of consciousness—Etoposide—brain cancer	0.000337	0.000618	CcSEcCtD
Pramipexole—Cough—Etoposide—brain cancer	0.000335	0.000613	CcSEcCtD
Pramipexole—Pain—Temozolomide—brain cancer	0.000335	0.000613	CcSEcCtD
Pramipexole—Constipation—Temozolomide—brain cancer	0.000335	0.000613	CcSEcCtD
Pramipexole—Feeling abnormal—Carmustine—brain cancer	0.000334	0.000611	CcSEcCtD
Pramipexole—Convulsion—Etoposide—brain cancer	0.000333	0.000609	CcSEcCtD
Pramipexole—Hypertension—Etoposide—brain cancer	0.000331	0.000607	CcSEcCtD
Pramipexole—Dizziness—Hydroxyurea—brain cancer	0.000331	0.000607	CcSEcCtD
Pramipexole—Gastrointestinal pain—Carmustine—brain cancer	0.000331	0.000606	CcSEcCtD
Pramipexole—Chest pain—Etoposide—brain cancer	0.000327	0.000598	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000325	0.000594	CcSEcCtD
Pramipexole—Discomfort—Etoposide—brain cancer	0.000323	0.000591	CcSEcCtD
Pramipexole—Feeling abnormal—Temozolomide—brain cancer	0.000323	0.000591	CcSEcCtD
Pramipexole—Body temperature increased—Carmustine—brain cancer	0.00032	0.000586	CcSEcCtD
Pramipexole—Abdominal pain—Carmustine—brain cancer	0.00032	0.000586	CcSEcCtD
Pramipexole—Gastrointestinal pain—Temozolomide—brain cancer	0.00032	0.000586	CcSEcCtD
Pramipexole—Vomiting—Hydroxyurea—brain cancer	0.000319	0.000583	CcSEcCtD
Pramipexole—Rash—Hydroxyurea—brain cancer	0.000316	0.000578	CcSEcCtD
Pramipexole—Confusional state—Etoposide—brain cancer	0.000316	0.000578	CcSEcCtD
Pramipexole—Dermatitis—Hydroxyurea—brain cancer	0.000316	0.000578	CcSEcCtD
Pramipexole—Headache—Hydroxyurea—brain cancer	0.000314	0.000575	CcSEcCtD
Pramipexole—Infection—Etoposide—brain cancer	0.000311	0.00057	CcSEcCtD
Pramipexole—Urticaria—Temozolomide—brain cancer	0.000311	0.000569	CcSEcCtD
Pramipexole—Abdominal pain—Temozolomide—brain cancer	0.000309	0.000567	CcSEcCtD
Pramipexole—Body temperature increased—Temozolomide—brain cancer	0.000309	0.000567	CcSEcCtD
Pramipexole—Thrombocytopenia—Etoposide—brain cancer	0.000307	0.000562	CcSEcCtD
Pramipexole—Tachycardia—Etoposide—brain cancer	0.000306	0.00056	CcSEcCtD
Pramipexole—Skin disorder—Etoposide—brain cancer	0.000304	0.000557	CcSEcCtD
Pramipexole—Hyperhidrosis—Etoposide—brain cancer	0.000303	0.000554	CcSEcCtD
Pramipexole—Anorexia—Etoposide—brain cancer	0.000299	0.000547	CcSEcCtD
Pramipexole—Hypersensitivity—Carmustine—brain cancer	0.000298	0.000546	CcSEcCtD
Pramipexole—Nausea—Hydroxyurea—brain cancer	0.000298	0.000545	CcSEcCtD
Pramipexole—Hypotension—Etoposide—brain cancer	0.000293	0.000536	CcSEcCtD
Pramipexole—Asthenia—Carmustine—brain cancer	0.000291	0.000532	CcSEcCtD
Pramipexole—Hypersensitivity—Temozolomide—brain cancer	0.000288	0.000528	CcSEcCtD
Pramipexole—Paraesthesia—Etoposide—brain cancer	0.000281	0.000515	CcSEcCtD
Pramipexole—Asthenia—Temozolomide—brain cancer	0.000281	0.000514	CcSEcCtD
Pramipexole—Dyspnoea—Etoposide—brain cancer	0.000279	0.000511	CcSEcCtD
Pramipexole—Somnolence—Etoposide—brain cancer	0.000278	0.00051	CcSEcCtD
Pramipexole—Diarrhoea—Carmustine—brain cancer	0.000277	0.000507	CcSEcCtD
Pramipexole—Pruritus—Temozolomide—brain cancer	0.000277	0.000507	CcSEcCtD
Pramipexole—Decreased appetite—Etoposide—brain cancer	0.000272	0.000499	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Etoposide—brain cancer	0.00027	0.000495	CcSEcCtD
Pramipexole—Fatigue—Etoposide—brain cancer	0.00027	0.000494	CcSEcCtD
Pramipexole—Dizziness—Carmustine—brain cancer	0.000268	0.00049	CcSEcCtD
Pramipexole—Constipation—Etoposide—brain cancer	0.000268	0.00049	CcSEcCtD
Pramipexole—Pain—Etoposide—brain cancer	0.000268	0.00049	CcSEcCtD
Pramipexole—Diarrhoea—Temozolomide—brain cancer	0.000268	0.00049	CcSEcCtD
Pramipexole—Dizziness—Temozolomide—brain cancer	0.000259	0.000474	CcSEcCtD
Pramipexole—Feeling abnormal—Etoposide—brain cancer	0.000258	0.000473	CcSEcCtD
Pramipexole—Vomiting—Carmustine—brain cancer	0.000258	0.000472	CcSEcCtD
Pramipexole—Gastrointestinal pain—Etoposide—brain cancer	0.000256	0.000469	CcSEcCtD
Pramipexole—Rash—Carmustine—brain cancer	0.000255	0.000468	CcSEcCtD
Pramipexole—Dermatitis—Carmustine—brain cancer	0.000255	0.000467	CcSEcCtD
Pramipexole—Headache—Carmustine—brain cancer	0.000254	0.000465	CcSEcCtD
Pramipexole—Vomiting—Temozolomide—brain cancer	0.000249	0.000456	CcSEcCtD
Pramipexole—Urticaria—Etoposide—brain cancer	0.000249	0.000456	CcSEcCtD
Pramipexole—Abdominal pain—Etoposide—brain cancer	0.000248	0.000453	CcSEcCtD
Pramipexole—Body temperature increased—Etoposide—brain cancer	0.000248	0.000453	CcSEcCtD
Pramipexole—Rash—Temozolomide—brain cancer	0.000247	0.000452	CcSEcCtD
Pramipexole—Dermatitis—Temozolomide—brain cancer	0.000247	0.000451	CcSEcCtD
Pramipexole—Headache—Temozolomide—brain cancer	0.000245	0.000449	CcSEcCtD
Pramipexole—Nausea—Carmustine—brain cancer	0.000241	0.000441	CcSEcCtD
Pramipexole—Nausea—Temozolomide—brain cancer	0.000233	0.000426	CcSEcCtD
Pramipexole—Hypersensitivity—Etoposide—brain cancer	0.000231	0.000423	CcSEcCtD
Pramipexole—Asthenia—Etoposide—brain cancer	0.000225	0.000411	CcSEcCtD
Pramipexole—Pruritus—Etoposide—brain cancer	0.000222	0.000406	CcSEcCtD
Pramipexole—Diarrhoea—Etoposide—brain cancer	0.000214	0.000392	CcSEcCtD
Pramipexole—Dizziness—Etoposide—brain cancer	0.000207	0.000379	CcSEcCtD
Pramipexole—Vomiting—Etoposide—brain cancer	0.000199	0.000365	CcSEcCtD
Pramipexole—Rash—Etoposide—brain cancer	0.000198	0.000362	CcSEcCtD
Pramipexole—Dermatitis—Etoposide—brain cancer	0.000197	0.000361	CcSEcCtD
Pramipexole—Headache—Etoposide—brain cancer	0.000196	0.000359	CcSEcCtD
Pramipexole—Nausea—Etoposide—brain cancer	0.000186	0.000341	CcSEcCtD
Pramipexole—HTR1B—Signaling Pathways—IRS2—brain cancer	2.06e-05	0.000326	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—PIK3CG—brain cancer	2.06e-05	0.000326	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—PDGFRA—brain cancer	2.05e-05	0.000324	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—IL2—brain cancer	2.03e-05	0.000322	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	2.03e-05	0.000321	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IRS2—brain cancer	2.03e-05	0.00032	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	2.03e-05	0.00032	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—SPP1—brain cancer	2.02e-05	0.000319	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—NOTCH2—brain cancer	2.01e-05	0.000318	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—SPP1—brain cancer	1.99e-05	0.000315	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.98e-05	0.000313	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HES1—brain cancer	1.94e-05	0.000307	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IRS2—brain cancer	1.93e-05	0.000306	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—VEGFA—brain cancer	1.92e-05	0.000304	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—IL2—brain cancer	1.92e-05	0.000303	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VAV1—brain cancer	1.91e-05	0.000303	CbGpPWpGaD
Pramipexole—ADRA2B—Hemostasis—TP53—brain cancer	1.91e-05	0.000302	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—RELA—brain cancer	1.89e-05	0.0003	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—IL2—brain cancer	1.89e-05	0.000299	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VAV1—brain cancer	1.88e-05	0.000298	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—ERBB2—brain cancer	1.88e-05	0.000298	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—IL2—brain cancer	1.88e-05	0.000298	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HES1—brain cancer	1.88e-05	0.000297	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HES1—brain cancer	1.87e-05	0.000295	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—APC—brain cancer	1.86e-05	0.000294	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—PIK3CG—brain cancer	1.86e-05	0.000294	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	1.85e-05	0.000293	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.84e-05	0.000291	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IRS2—brain cancer	1.82e-05	0.000288	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—APC—brain cancer	1.82e-05	0.000288	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—PIK3CG—brain cancer	1.82e-05	0.000288	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.82e-05	0.000287	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HES1—brain cancer	1.81e-05	0.000287	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.81e-05	0.000286	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IRS2—brain cancer	1.8e-05	0.000285	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.8e-05	0.000284	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—SPP1—brain cancer	1.8e-05	0.000284	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—PIK3CG—brain cancer	1.79e-05	0.000283	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—APC—brain cancer	1.79e-05	0.000283	CbGpPWpGaD
Pramipexole—ADRA2C—Hemostasis—TP53—brain cancer	1.79e-05	0.000282	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.79e-05	0.000282	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.78e-05	0.000281	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—IL2—brain cancer	1.76e-05	0.000278	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—SPP1—brain cancer	1.73e-05	0.000274	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	1.73e-05	0.000273	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—SPP1—brain cancer	1.72e-05	0.000273	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.71e-05	0.000271	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—IL2—brain cancer	1.71e-05	0.00027	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—PIK3CG—brain cancer	1.71e-05	0.00027	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—APC—brain cancer	1.71e-05	0.00027	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—IL2—brain cancer	1.71e-05	0.00027	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—EGFR—brain cancer	1.69e-05	0.000268	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—SPP1—brain cancer	1.68e-05	0.000265	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CCND1—brain cancer	1.66e-05	0.000263	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—EGFR—brain cancer	1.66e-05	0.000262	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—IL2—brain cancer	1.65e-05	0.000261	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—PIK3CG—brain cancer	1.65e-05	0.000261	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HES1—brain cancer	1.65e-05	0.00026	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—CTNNB1—brain cancer	1.65e-05	0.00026	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—IL2—brain cancer	1.64e-05	0.00026	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—EGFR—brain cancer	1.63e-05	0.000258	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IRS2—brain cancer	1.62e-05	0.000257	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—HES1—brain cancer	1.62e-05	0.000256	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—APC—brain cancer	1.61e-05	0.000255	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—PIK3CG—brain cancer	1.61e-05	0.000255	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—PIK3CG—brain cancer	1.6e-05	0.000253	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—IL2—brain cancer	1.6e-05	0.000252	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—IL2—brain cancer	1.59e-05	0.000252	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—APC—brain cancer	1.59e-05	0.000251	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—PIK3CG—brain cancer	1.59e-05	0.000251	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.57e-05	0.000248	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PDGFRA—brain cancer	1.57e-05	0.000248	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IRS2—brain cancer	1.57e-05	0.000248	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IRS2—brain cancer	1.56e-05	0.000247	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—EGFR—brain cancer	1.56e-05	0.000246	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.54e-05	0.000244	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—PIK3CG—brain cancer	1.54e-05	0.000243	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—SPP1—brain cancer	1.52e-05	0.000241	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IRS2—brain cancer	1.52e-05	0.00024	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—SPP1—brain cancer	1.5e-05	0.000237	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HES1—brain cancer	1.47e-05	0.000233	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—EGFR—brain cancer	1.47e-05	0.000232	CbGpPWpGaD
Pramipexole—ADRA2A—Hemostasis—TP53—brain cancer	1.45e-05	0.000229	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—RELA—brain cancer	1.45e-05	0.000229	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—VEGFA—brain cancer	1.45e-05	0.000229	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—IL2—brain cancer	1.45e-05	0.000229	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—EGFR—brain cancer	1.45e-05	0.000229	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—ERBB2—brain cancer	1.44e-05	0.000228	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—STAT3—brain cancer	1.44e-05	0.000227	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	1.43e-05	0.000227	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—APC—brain cancer	1.43e-05	0.000227	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—IL2—brain cancer	1.43e-05	0.000226	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—IL2—brain cancer	1.43e-05	0.000225	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—RELA—brain cancer	1.42e-05	0.000225	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—ERBB2—brain cancer	1.41e-05	0.000223	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	1.4e-05	0.000222	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—RELA—brain cancer	1.4e-05	0.000221	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—ERBB2—brain cancer	1.39e-05	0.00022	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—APC—brain cancer	1.38e-05	0.000219	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—PIK3CG—brain cancer	1.38e-05	0.000219	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—APC—brain cancer	1.38e-05	0.000218	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—PIK3CG—brain cancer	1.38e-05	0.000218	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IRS2—brain cancer	1.38e-05	0.000218	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—SPP1—brain cancer	1.36e-05	0.000216	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IRS2—brain cancer	1.35e-05	0.000214	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	1.34e-05	0.000212	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—APC—brain cancer	1.34e-05	0.000212	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—RELA—brain cancer	1.33e-05	0.000211	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—MYC—brain cancer	1.33e-05	0.000211	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—ERBB2—brain cancer	1.33e-05	0.00021	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—EGFR—brain cancer	1.31e-05	0.000207	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—IL2—brain cancer	1.31e-05	0.000207	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—EGFR—brain cancer	1.3e-05	0.000206	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—PIK3CG—brain cancer	1.3e-05	0.000206	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—IL2—brain cancer	1.3e-05	0.000205	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—IL2—brain cancer	1.28e-05	0.000202	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CCND1—brain cancer	1.27e-05	0.000201	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—EGFR—brain cancer	1.26e-05	0.0002	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.26e-05	0.000199	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—IL2—brain cancer	1.26e-05	0.000199	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—RELA—brain cancer	1.26e-05	0.000199	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—EGFR—brain cancer	1.26e-05	0.000199	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—ERBB2—brain cancer	1.25e-05	0.000198	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CCND1—brain cancer	1.25e-05	0.000197	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—RELA—brain cancer	1.24e-05	0.000196	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.23e-05	0.000195	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—ERBB2—brain cancer	1.23e-05	0.000195	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IRS2—brain cancer	1.23e-05	0.000195	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CCND1—brain cancer	1.23e-05	0.000194	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—EGFR—brain cancer	1.22e-05	0.000193	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—PIK3CG—brain cancer	1.22e-05	0.000192	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—APC—brain cancer	1.22e-05	0.000192	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—CTNNB1—brain cancer	1.22e-05	0.000192	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—IL2—brain cancer	1.2e-05	0.00019	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—APC—brain cancer	1.2e-05	0.000189	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—PIK3CG—brain cancer	1.2e-05	0.000189	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CCND1—brain cancer	1.17e-05	0.000185	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—CTNNB1—brain cancer	1.16e-05	0.000183	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—IL2—brain cancer	1.13e-05	0.000179	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—RELA—brain cancer	1.12e-05	0.000177	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—IL2—brain cancer	1.12e-05	0.000177	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—ERBB2—brain cancer	1.11e-05	0.000176	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—VEGFA—brain cancer	1.11e-05	0.000176	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—EGFR—brain cancer	1.11e-05	0.000175	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CCND1—brain cancer	1.1e-05	0.000175	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—STAT3—brain cancer	1.1e-05	0.000174	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—TP53—brain cancer	1.1e-05	0.000173	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—CTNNB1—brain cancer	1.09e-05	0.000173	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CCND1—brain cancer	1.09e-05	0.000172	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—EGFR—brain cancer	1.09e-05	0.000172	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—APC—brain cancer	1.09e-05	0.000172	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	1.09e-05	0.000172	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—VEGFA—brain cancer	1.09e-05	0.000172	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—RELA—brain cancer	1.08e-05	0.000171	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—CTNNB1—brain cancer	1.08e-05	0.000171	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—RELA—brain cancer	1.08e-05	0.00017	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—STAT3—brain cancer	1.08e-05	0.00017	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—ERBB2—brain cancer	1.08e-05	0.00017	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—VEGFA—brain cancer	1.07e-05	0.000169	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—ERBB2—brain cancer	1.07e-05	0.000169	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—STAT3—brain cancer	1.06e-05	0.000168	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—RELA—brain cancer	1.05e-05	0.000166	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—ERBB2—brain cancer	1.04e-05	0.000165	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—MYC—brain cancer	1.02e-05	0.000162	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—VEGFA—brain cancer	1.02e-05	0.000162	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—STAT3—brain cancer	1.01e-05	0.00016	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—IL2—brain cancer	1.01e-05	0.00016	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—MYC—brain cancer	1e-05	0.000158	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—EGFR—brain cancer	9.99e-06	0.000158	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—EGFR—brain cancer	9.92e-06	0.000157	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—MYC—brain cancer	9.84e-06	0.000156	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CCND1—brain cancer	9.84e-06	0.000156	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—EGFR—brain cancer	9.78e-06	0.000155	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	9.74e-06	0.000154	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—IL2—brain cancer	9.74e-06	0.000154	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—IL2—brain cancer	9.69e-06	0.000153	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—VEGFA—brain cancer	9.63e-06	0.000152	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—EGFR—brain cancer	9.63e-06	0.000152	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—STAT3—brain cancer	9.54e-06	0.000151	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—VEGFA—brain cancer	9.5e-06	0.00015	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—RELA—brain cancer	9.5e-06	0.00015	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CCND1—brain cancer	9.5e-06	0.00015	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CCND1—brain cancer	9.45e-06	0.000149	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—ERBB2—brain cancer	9.44e-06	0.000149	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—IL2—brain cancer	9.43e-06	0.000149	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—STAT3—brain cancer	9.41e-06	0.000149	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—CTNNB1—brain cancer	9.41e-06	0.000149	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—MYC—brain cancer	9.4e-06	0.000149	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—CTNNB1—brain cancer	9.36e-06	0.000148	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—RELA—brain cancer	9.35e-06	0.000148	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—ERBB2—brain cancer	9.29e-06	0.000147	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CCND1—brain cancer	9.19e-06	0.000145	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—EGFR—brain cancer	9.19e-06	0.000145	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	9.1e-06	0.000144	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—MYC—brain cancer	8.86e-06	0.00014	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—MYC—brain cancer	8.74e-06	0.000138	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—EGFR—brain cancer	8.67e-06	0.000137	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—VEGFA—brain cancer	8.58e-06	0.000136	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—IL2—brain cancer	8.56e-06	0.000135	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—EGFR—brain cancer	8.55e-06	0.000135	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—RELA—brain cancer	8.5e-06	0.000135	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—STAT3—brain cancer	8.49e-06	0.000134	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—ERBB2—brain cancer	8.45e-06	0.000134	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—IL2—brain cancer	8.42e-06	0.000133	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—TP53—brain cancer	8.39e-06	0.000133	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CCND1—brain cancer	8.34e-06	0.000132	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—VEGFA—brain cancer	8.28e-06	0.000131	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—CTNNB1—brain cancer	8.26e-06	0.000131	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—VEGFA—brain cancer	8.24e-06	0.00013	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—TP53—brain cancer	8.21e-06	0.00013	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CCND1—brain cancer	8.21e-06	0.00013	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—STAT3—brain cancer	8.2e-06	0.00013	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—STAT3—brain cancer	8.16e-06	0.000129	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—CTNNB1—brain cancer	8.13e-06	0.000129	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—TP53—brain cancer	8.08e-06	0.000128	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—VEGFA—brain cancer	8.01e-06	0.000127	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—STAT3—brain cancer	7.93e-06	0.000125	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—MYC—brain cancer	7.89e-06	0.000125	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—EGFR—brain cancer	7.72e-06	0.000122	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—TP53—brain cancer	7.72e-06	0.000122	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—IL2—brain cancer	7.66e-06	0.000121	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—MYC—brain cancer	7.62e-06	0.000121	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—MYC—brain cancer	7.58e-06	0.00012	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CCND1—brain cancer	7.47e-06	0.000118	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—EGFR—brain cancer	7.45e-06	0.000118	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—EGFR—brain cancer	7.41e-06	0.000117	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	7.39e-06	0.000117	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—MYC—brain cancer	7.37e-06	0.000117	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—TP53—brain cancer	7.28e-06	0.000115	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—VEGFA—brain cancer	7.27e-06	0.000115	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—EGFR—brain cancer	7.21e-06	0.000114	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—STAT3—brain cancer	7.2e-06	0.000114	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—TP53—brain cancer	7.18e-06	0.000114	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—VEGFA—brain cancer	7.15e-06	0.000113	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—STAT3—brain cancer	7.08e-06	0.000112	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—MYC—brain cancer	6.69e-06	0.000106	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—MYC—brain cancer	6.58e-06	0.000104	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—EGFR—brain cancer	6.54e-06	0.000103	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—VEGFA—brain cancer	6.51e-06	0.000103	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—TP53—brain cancer	6.48e-06	0.000103	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—STAT3—brain cancer	6.44e-06	0.000102	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—EGFR—brain cancer	6.44e-06	0.000102	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—TP53—brain cancer	6.26e-06	9.9e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—TP53—brain cancer	6.23e-06	9.85e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—TP53—brain cancer	6.06e-06	9.58e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—MYC—brain cancer	5.99e-06	9.47e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—EGFR—brain cancer	5.86e-06	9.26e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—TP53—brain cancer	5.49e-06	8.69e-05	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—TP53—brain cancer	5.41e-06	8.55e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—TP53—brain cancer	4.92e-06	7.78e-05	CbGpPWpGaD
